Immunovant, Inc.IMVTNASDAQ
Loading
Current Ratio Over TimeNormalizing
Percentile Rank57
3Y CAGR-1.1%
5Y CAGR+9.4%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
-1.1%/yr
vs +257.8%/yr prior
5Y CAGR
+9.4%/yr
Recent deceleration
Acceleration
-258.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
202511.16-18.5%
202413.70+46.7%
20239.34-18.9%
202211.52-47.1%
202121.79+206.0%
20207.12+733.6%
20190.85+1115.2%
20180.07-